id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-252305-rstxyofq	Tyan, Kevin	Considerations for the Selection and Use of Disinfectants Against SARS-CoV-2 in a Healthcare Setting	2020-08-31		.txt	text/plain	2062	156	49	We then developed a streamlined set of guidelines to help rapidly evaluate and select suitable disinfectants from List N, including practicality, efficacy, safety, and cost/availability. While this list appears extensive, it lacks guidance or discussion of practical concerns that must be taken into consideration when selecting a disinfectant during this pandemic, including efficacy, practicality, safety profile, and availability. Some products on List N do not have an emerging viral pathogen claim but have been included because they 1) demonstrate efficacy against another human coronavirus similar to SARS-CoV-2 or 2) are EPA-approved against select viruses that are harder-to-kill [5] . The publication of the EPA List N was an important step in providing a resource for selecting disinfectants against SARS-CoV-2 and can be more easily operationalized in healthcare settings when supplemented with additional data on safety, practicality, and availability.	./cache/cord-252305-rstxyofq.txt	./txt/cord-252305-rstxyofq.txt